Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis M Staudt

Showing results (11-20 of 286) with videos related to

Pageof 29
Sort By:
Seminars in Hematology|October 29, 2003
Towards molecular diagnosis and targeted therapy of lymphoid malignanciesAdrian Wiestner, Louis M Staudt
Immunological Reviews|December 17, 2014
Protein ubiquitination in lymphoid malignanciesYibin Yang, Louis M Staudt
Seminars in Oncology|June 14, 2002
Clinical translation of gene expression profiling in lymphomas and leukemiasAndreas Rosenwald, Louis M Staudt
Cancer Cell|December 15, 2012
A new "brew" of MALT1 inhibitorsRyan M Young, Louis M Staudt
Nature Reviews. Drug Discovery|March 2, 2013
Targeting pathological B cell receptor signalling in lymphoid malignanciesRyan M Young, Louis M Staudt
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2020
CRISPR-based technology to silence the expression of IncRNAsJames D Phelan, Louis M Staudt
Cancer Cell|July 16, 2014
Ibrutinib treatment of CLL: the cancer fights backRyan M Young, Louis M Staudt
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2015
Bill Paul: The heart of immunologyMichael J Lenardo, Louis M Staudt
Cancer Cell|November 27, 2002
Focus on lymphomasLouis M Staudt, Wyndham H Wilson
Nature|July 26, 2023
Double-headed molecule activates cell-death pathways in cancer cellsJames D Phelan, Louis M Staudt
Pageof 29

Showing results (11-20 of 286) with videos related to

Sort By:
Pageof 29
Seminars in Hematology|October 29, 2003
Towards molecular diagnosis and targeted therapy of lymphoid malignanciesAdrian Wiestner, Louis M Staudt
Immunological Reviews|December 17, 2014
Protein ubiquitination in lymphoid malignanciesYibin Yang, Louis M Staudt
Seminars in Oncology|June 14, 2002
Clinical translation of gene expression profiling in lymphomas and leukemiasAndreas Rosenwald, Louis M Staudt
Cancer Cell|December 15, 2012
A new "brew" of MALT1 inhibitorsRyan M Young, Louis M Staudt
Nature Reviews. Drug Discovery|March 2, 2013
Targeting pathological B cell receptor signalling in lymphoid malignanciesRyan M Young, Louis M Staudt
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2020
CRISPR-based technology to silence the expression of IncRNAsJames D Phelan, Louis M Staudt
Cancer Cell|July 16, 2014
Ibrutinib treatment of CLL: the cancer fights backRyan M Young, Louis M Staudt
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2015
Bill Paul: The heart of immunologyMichael J Lenardo, Louis M Staudt
Cancer Cell|November 27, 2002
Focus on lymphomasLouis M Staudt, Wyndham H Wilson
Nature|July 26, 2023
Double-headed molecule activates cell-death pathways in cancer cellsJames D Phelan, Louis M Staudt
Pageof 29